Related Experiment Video
Updated: Jun 7, 2026
Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
Does valproic acid induce neuroendocrine differentiation in prostate cancer?
Abhinav Sidana1, Muwen Wang, Wasim H Chowdhury
1James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Marburg 205A, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Valproic Acid (VPA) does not induce neuroendocrine differentiation in prostate cancer (PCa) cells in vivo. While some markers showed minor changes in vitro, VPA did not promote PCa neuroendocrine changes in a relevant biological setting.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Valproic Acid (VPA) is a histone deacetylase inhibitor with potential in cancer therapy.
- Neuroendocrine differentiation (NED) is a process observed in some prostate cancers (PCa).
Purpose of the Study:
- To investigate if Valproic Acid (VPA) induces neuroendocrine differentiation (NED) in prostate cancer (PCa).
Main Methods:
- Tissue microarray analysis of VPA-treated and untreated human PCa xenografts and cell lines (LNCaP, C4-2, DU145, PC-3).
- Immunohistochemical analysis (IHC) for neuroendocrine markers: chromogranin A (CgA), synaptophysin, and NCAM.
- Western blot analysis for CgA confirmation.
Main Results:
- In vivo: VPA treatment did not induce CgA, synaptophysin, or NCAM in xenografts.
- In vitro: VPA showed minimal induction of synaptophysin (C4-2, PC-3) and NCAM (LNCaP, PC-3).
- In vitro: VPA decreased CgA expression dose-dependently (Western blot).
Conclusions:
- Valproic Acid (VPA) does not induce neuroendocrine differentiation in prostate cancer (PCa) cells in vivo.
- Observed in vitro effects were minimal and VPA decreased a key neuroendocrine marker (CgA).
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
08:36Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019